Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 786 GBX 0.56% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Genus PLC?
Write Note

Genus PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genus PLC
Accounts Payable Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Genus PLC
LSE:GNS
Accounts Payable
ÂŁ123.2m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
9%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Accounts Payable
$11.8m
CAGR 3-Years
128%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Accounts Payable
ÂŁ11.3m
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Accounts Payable
$103k
CAGR 3-Years
-64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Accounts Payable
$5.7m
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Accounts Payable
ÂŁ17.8m
CAGR 3-Years
45%
CAGR 5-Years
23%
CAGR 10-Years
N/A

See Also

What is Genus PLC's Accounts Payable?
Accounts Payable
123.2m GBP

Based on the financial report for Jun 30, 2024, Genus PLC's Accounts Payable amounts to 123.2m GBP.

What is Genus PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
9%

Over the last year, the Accounts Payable growth was 254%. The average annual Accounts Payable growth rates for Genus PLC have been 4% over the past three years , 7% over the past five years , and 9% over the past ten years .

Back to Top